Javelin Pharmaceuticals Inc

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	48
ISBN Number	not applicable
Product Code	DAT11477

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

Javelin Pharmaceuticals is a late development stage specialty pharmaceutical company that discovers, develops and commercializes drugs and improved formulations of existing drugs that target pain management market.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Javelin Pharmaceuticals' product candidates include Dyloject, which is in Phase III development stage for the treatment of post-operative pain in the US. It's pipeline also include Rylomine, an intranasal formulation of morphine that is in Phase III for the treatment of acute moderate-to-severe pain and breakthrough pain in the US and Europe; Javelin Pharmaceuticals derives its entire revenues from grants received from the US Department of Defense (DOD) and the National Institutes of Health (NIH) for the development and clinical advancement of PMI-150. The company's total revenues increased at a CAGR of 31% during 2002-2006, from $0.3 million to $0.8 million. Javelin Pharmaceuticals is expected to witness an absolute growth of +$143 million with sales of $0.8 million in 2006 increasing to $143 million in 2010. The major contributor to this absolute growth is expected to be driven by the product launch of Dyloject in the year 2008 in most of the EU countries.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Top Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
- Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Javelin Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Javelin Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
Table of Tables
- Table 1: Javelin Pharmaceuticals - Key Facts
- Table 2: Javelin Pharmaceuticals - Other Locations and Subsidiaries
- Table 3: Javelin Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Javelin Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: Javelin Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Javelin Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 7: Javelin Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Javelin Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Javelin Pharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Javelin Pharmaceuticals - in-House Pipeline Products
- Table 11: Javelin Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 12: Javelin Pharmaceuticals - Top Competitors
- Table 13: Javelin Pharmaceuticals - Key Suppliers
- Table 14: Javelin Pharmaceuticals - Key Clients
- Table 15: Javelin Pharmaceuticals - Key Shareholders
- Table 16: Javelin Pharmaceuticals - SWOT Analysis Summary
- Table 17: Javelin Pharmaceuticals - Value Chain Analysis
- Table 18: Javelin Pharmaceuticals - Scorecard
- Table 19: Javelin Pharmaceuticals - Key Employees
- Table 20: Javelin Pharmaceuticals - Financial and Operational Overview